Indogulf Cropsciences Q1 FY27: Revenue Up 19% YoY to ₹7,046 Crore
Indogulf Cropsciences reported Q1 FY27 revenue of ₹7,046 Crore, up 19% YoY. PAT increased 27% YoY to ₹400 Crore, and EBITDA rose 15% YoY to ₹740 Crore. The company is transitioning to an integrated agri-solutions platform, focusing on biologicals, farmer engagement, and global expansion. Q1 FY27 operational revenue was ₹1,685 Crore.
The announcement of significant YoY growth in key financial metrics (Revenue, EBITDA, PAT) and the strategic direction towards becoming an integrated agri-solutions platform are material events for investors and the market.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT for the fiscal year 2026, indicating positive financial performance and strategic progress.
Indogulf Cropsciences Limited has released its investor presentation for the first quarter of the fiscal year 2026-27 (Q1 FY27), with the earnings call scheduled for August 18, 2026. The company reported a significant 19% year-on-year increase in revenue for Q1 FY27, reaching ₹7,046 Crore (₹70.46 billion). EBITDA saw a 15% YoY rise to ₹740 Crore (₹7.40 billion), and Profit After Tax (PAT) surged by 27% YoY to ₹400 Crore (₹4.00 billion).
The company highlighted its strategic shift from being a product-centric entity to an integrated agri-solutions platform. Key strengths include a comprehensive integrated agri-solutions portfolio, manufacturing excellence with backward integration, a wide distribution and market reach, deep farmer engagement through an advisory-led approach, and a growing global presence with exports to 36+ countries. Indogulf Cropsciences is focusing on expanding its biologicals and sustainable product portfolio, increasing the contribution of high-margin products, deepening farmer engagement, accelerating global expansion, strengthening operational excellence, and driving innovation-led growth.
In Q1 FY27, revenue from operations stood at ₹1,685 Crore, a 11% decrease YoY, while EBITDA was ₹96 Crore (down 4% YoY) and PAT was ₹24 Crore (down 38% YoY). The revenue mix for Q1 FY27 shows Crop Protection dominating at 87%, followed by Others at 7%, and Biologicals and Plant Nutrients each at 3%. The B2C channel contributed 47% to the revenue, B2B at 31%, Exports at 13%, and Others at 9%.
The company's balance sheet as of FY26 shows total equity of ₹4,593 Crore and total liabilities of ₹3,640 Crore. Assets totaled ₹8,234 Crore, with inventories at ₹3,435 Crore and trade receivables at ₹2,406 Crore. Indogulf Cropsciences aims to evolve into an integrated agri-solutions platform focused on sustainable growth and long-term value creation, emphasizing innovation, farmer connect, and global reach.
What to do with a filing like this
Indogulf Cropsciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indogulf Cropsciences Limited. Read the original for the full detail.